In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Area of interest

Area of interest

Type 2 selected

Type

Guidance programme 10 selected

Guidance programme

Showing 1 to 6 of 6

TitleConsultationTypeConsultation end date
Bimekizumab for treating moderate to severe hidradenitis suppurativa [ID6134]Draft guidanceTechnology appraisal guidance
Fruquintinib for previously treated metastatic colorectal cancer ID6274Draft guidanceTechnology appraisal guidance
Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225]Draft guidanceTechnology appraisal guidance
Intrapartum care - uterotonics for postpartum haemorrhageDraft guidance consultationNICE guideline
Cabotegravir for preventing HIV-1 in adults and young people [ID6255]Draft guidanceTechnology appraisal guidance
Fosdenopterin for treating molybdenum cofactor deficiency type A [ID6264]Evaluation consultationHighly specialised technology

Results per page

  1. 10
  2. 25
  3. 50
  4. All